Sensitive high-performance liquid chromatographic determination of EM523, a new erythromycin derivative, in human plasma and urine with ultraviolet detection using column switching.
K Yamashita, M Motohashi, T Yashiki
Index: J. Chromatogr. A. 616(1) , 144-50, (1993)
Full Text: HTML
Abstract
A sensitive high-performance liquid chromatographic (HPLC) method using column switching is described for the determination of EM523 (I), a new erythromycin derivative, in human plasma and urine. The analyte was extracted from alkalinized plasma or urine with a mixture of n-hexane and acetone. After the evaporation of the organic layer, the reconstituted residue was injected into the HPLC system and separated on the first column. After column switching, the heart-cut fraction contamination the analyte was further separated on the second column and monitored by ultraviolet absorbance at 210 nm. The detection limits were 1 ng/ml in plasma and 10 ng/ml in urine. The method was applied to the clinical trials of I.
Related Compounds
Related Articles:
1993-10-01
[Jpn. J. Pharmacol. 63(2) , 209-17, (1993)]
1996-01-01
[Peptides 17(6) , 895-900, (1996)]
1997-08-15
[Regul. Pept. 71(2) , 87-95, (1997)]
2007-01-01
[Pharmacology 79(3) , 137-48, (2007)]
1996-08-01
[J. Antibiot. 49(8) , 794-801, (1996)]